Genetic Variants Replication Study Associated With Dependence on Sulfonylurea in Participants With Type 2 Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

September 10, 2019

Primary Completion Date

November 30, 2020

Study Completion Date

November 30, 2020

Conditions
Diabetes Mellitus
Interventions
DRUG

discontinuation of Sulfonylureas

"1. Discontinuation of sulfonylurea, alternative drug administration.~2. If there is a significant increase in blood glucose, it is considered as a sulfonylurea-dependent patient. Discontinue the alternative drug and resume the sulfonylurea, and monitor for 12 weeks or until stabilization of blood glucose at short intervals.~3. if blood glucose levels are within optimal range after replacement of sulfonylureas with other agents, the patient is regard as non-SU-dependent"

Trial Locations (1)

110-144

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT04123587 - Genetic Variants Replication Study Associated With Dependence on Sulfonylurea in Participants With Type 2 Diabetes | Biotech Hunter | Biotech Hunter